Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting

Breast Cancer. 2023 Nov;30(6):1065-1078. doi: 10.1007/s12282-023-01501-1. Epub 2023 Sep 11.

Abstract

Background: Allyl isothiocyanate (AITC) is an excellent active phytoconstituent recently revealed for cancer treatment. The strategic prominence of this study was to synthesize and characterize AITC-embedded tripolyphosphate-modified chitosan nanoparticles (AITC@CS-TPP-NPs) by ionic gelation.

Method: Chitosan is recycled as a polymer to fabricate AITC@CS-TPP-NPs; the fabricated nanoparticles (NPs) are then characterized using FT-IR spectroscopy, DSC, XRD, zeta potential, size analysis, SEM, EDX, entrapment efficiency, in vitro drug release study, and in vitro cytotoxicity activity against MCF-7 to explore the effectiveness and strength.

Results: As a result, developed AITC@CS-TPP-NPs demonstrates good stability with a zeta potential of 35.83 mV and 90.14% of drug release. The anticancer potential of AITC@CS-TPP-NPs shows the improved cytotoxicity activity of AITC due to the surface modification of CS using TPP. Hence, the cytotoxicity of AITC@CS-TPP-NPs was tested in vitro against a human breast cancer cell line (MCF-7) and found to be considerable.

Conclusion: The AITC@CS-TPP-NPs were effectively synthesized and have significant benefits, including being easy to prepare, stable, and affordable with wide use in human breast cancer against cell line (MCF-7).

Keywords: Allyl isothiocyanate; Breast cancer; Chitosan; Nanoparticles; Tripolyphosphate.

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Chitosan* / chemistry
  • Female
  • Humans
  • Isothiocyanates / pharmacology
  • Nanoparticles* / chemistry
  • Spectroscopy, Fourier Transform Infrared

Substances

  • 2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate
  • allyl isothiocyanate
  • Chitosan
  • Isothiocyanates